Foresite Capital Management Iv, LLC Pharvaris N.V. Transaction History
Foresite Capital Management Iv, LLC
- $153 Million
- Q3 2024
A detailed history of Foresite Capital Management Iv, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 4,397,881 shares of PHVS stock, worth $89.5 Million. This represents 53.23% of its overall portfolio holdings.
Number of Shares
4,397,881
Previous 4,293,854
2.42%
Holding current value
$89.5 Million
Previous $80.7 Million
0.9%
% of portfolio
53.23%
Previous 54.23%
Shares
6 transactions
Others Institutions Holding PHVS
# of Institutions
51Shares Held
39.6MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$153 Million3.99% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$87.3 Million65.3% of portfolio
-
Viking Global Investors LP3.65MShares$74.3 Million0.26% of portfolio
-
Vr Adviser, LLC New York, NY3.4MShares$69.1 Million6.51% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$67.2 Million10.98% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $687M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...